Skip to main content
Figure 1 | Cardiovascular Diabetology

Figure 1

From: Effect of vildagliptin, a dipeptidyl peptidase 4 inhibitor, on cardiac hypertrophy induced by chronic beta-adrenergic stimulation in rats

Figure 1

Effects of vildagliptin on glucose tolerance, active GLP-1 levels, and DPP4 activity in isoproterenol-treated rats. Plots of blood glucose over time (A), levels of active plasma glucagon-like peptide (GLP)-1 (B), and dipeptidyl peptidase (DPP)-4 activity (C) in vehicle, ISO, ISO-VL, and vehicle-VL groups. Data represent the mean ± SE of 10 rats. *p < 0.05 vs. the vehicle and ISO groups.

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840